CANDY MUNGARRO-RUBIO: Open Payments
NPI 1114697067 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 8 payments from 8 companies in 2025. Trend: 2023 $124 · 2024 $193 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $68 |
| GENZYME CORPORATION | 1 | $36 |
| Integra LifeSciences Corporation | 1 | $33 |
| Lilly USA, LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| LEO Pharma Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DAXXIFY, DUPIXENT, OMNIGRAFT, EBGLYSS, COSENTYX, BOTOX, ANZUPGO, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
